Literature DB >> 33830538

Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019.

Kameran M Ali1, Ayad M Ali2, Hassan M Tawfeeq1, Grazziela P Figueredo3, Hassan M Rostam4,5.   

Abstract

Coronavirus disease 2019 (COVID-19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term. Here, we examined erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum albumin biomarkers in patients with a history of severe and mild-to-moderate COVID-19 following their recovery. In patients with severe COVID-19 serum albumin had a strong negative correlation with both ESR and CRP levels (R2  = - 0.861 and R2  = - 0.711), respectively. Also, there was a positive correlation between ESR and CRP level (R2  = 0.85) in the same group. However, there was no correlation between these biomarkers among mild-to-moderate COVID-19 patients. In addition, no correlation was recorded between the severe and mild-to-moderate COVID-19 groups. This finding highlights the sustained elevation of ESR and CRP level and reduced serum albumin level that may persist postrecovery in patients with a history of severe COVID-19.
© 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; CRP; ESR; postrecovery; serum albumin

Year:  2021        PMID: 33830538     DOI: 10.1002/jmv.27002

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  The Impact of Serum Albumin Levels on COVID-19 Mortality.

Authors:  Verena Zerbato; Gianfranco Sanson; Marina De Luca; Stefano Di Bella; Alessandra di Masi; Pietro Caironi; Bruna Marini; Rudy Ippodrino; Roberto Luzzati
Journal:  Infect Dis Rep       Date:  2022-04-20

2.  Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients.

Authors:  Ayad M Ali; Hassan M Rostam; Mohammed H Fatah; Chalak M Noori; Kameran M Ali; Hassan M Tawfeeq
Journal:  Immun Inflamm Dis       Date:  2021-12-22

3.  Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of Iraq.

Authors:  Hussein Noori Ali; Kameran Mohammed Ali; Hassan Muhammad Rostam; Ayad M Ali; Hassan Mohammad Tawfeeq; Mohammed Hassan Fatah; Grazziela P Figueredo
Journal:  Pract Lab Med       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.